Abraxis acquires rights to discovery platform
Abraxis Bioscience has bought the worldwide rights to a discovery platform designed to generate new therapeutics and identify new drug targets that alter the p53 tumour suppressor signalling pathway.
Archives for August 7, 2007
Cambrex profit rises despite flat sales
Cambrex has recorded an increase in operating profit in its second quarter financial results despite flat sales.
Gilead scraps new plant to acquire Nycomed facility
US-based Gilead Sciences has ditched its plans to build a new €60m plant in Dublin, Ireland, instead acquiring Nycomed's Irish manufacturing facility in Cork for almost €34m.
Innovaderm Research, Target Health, Qualia Clinical Service, and Quintiles – Clinical contract news
Outsourcing-Pharma.com compiles the news that featured in the clinical contract community this past week, involving Innovaderm Research, Target Health, Qualia Clinical Service, and Quintiles.
Biotech firm Archemix strengthens alliances
Following Archemix' initial public offering (IPO) filing the company has announced two high profile strategic alliances aimed at leveraging its aptamer technology to a wider audience.
China declares $1.7bn drug safety investment
China has announced an initial $1.7bn investment to bolster its currently questionable ability to effectively monitor the quality of the food and drugs manufactured within its borders.
Baxter recalls more infusion pumps
Baxter Healthcare remains in murky waters in regard to its infusion pumps after announcing yesterday it would be recalling an additional 986 of its Colleague brand pumps.
Weekly comment
Speculation on gene therapy trial death 'premature'
Targeted Genetics said it was 'premature as well as irresponsible' to draw any conclusions on what caused the death of a patient who participated in a clinical trial testing the safety of the firm's new gene therapy.